Screening for major diseases in community pharmacies

a systematic review

Abimbola Adebukola Ayorinde, Terry Porteous, Pawana Sharma

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

OBJECTIVES: The aim of this systematic review was to assess the published evidence about the feasibility and acceptability of community pharmacy-based screening for major diseases.

METHOD: Studies published between January 1990 and August 2012 involving community pharmacy-based screening interventions, published in the English language, were identified from electronic databases. Reference lists of included studies were also searched.

KEY FINDINGS: Fifty studies (one randomised controlled trial, two cluster randomised studies, five non-randomised comparative studies and 42 uncontrolled studies) were included. The quality of most of these was assessed as poor. Screening was mostly opportunistic and screening tools included questionnaires or risk assessment forms, medical equipment to make physiological measurements, or a combination of both. Few studies assessed the accuracy of pharmacy-based screening tools. More than half of the screening interventions included an element of patient education. The proportion of screened individuals, identified with disease risk factors or the disease itself, ranged from 4% to 89%. Only 10 studies reported any economic information. Where assessed, patient satisfaction with pharmacy-based screening was high, but individuals who screened positive often did not follow pharmacist advice to seek further medical help.

CONCLUSION: Available evidence suggests that screening for some diseases in community pharmacies is feasible. More studies are needed to compare effectiveness and cost-effectiveness of pharmacy-based screening with screening by other providers. Strategies to improve screening participants' adherence to pharmacist advice also need to be explored. This systematic review will help to inform future studies wishing to develop community pharmacy-based screening interventions.

Original languageEnglish
Pages (from-to)349-361
Number of pages13
JournalInternational Journal of Pharmacy Practice
Volume21
Issue number6
Early online date20 May 2013
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Pharmacies
Screening
Pharmacists
Patient Education
Patient Satisfaction
Cost-Benefit Analysis
Language
Randomized Controlled Trials
Economics
Databases
Equipment and Supplies
Biomedical equipment
Cost effectiveness
Risk assessment
Education

Keywords

  • community pharmacy services
  • humans
  • mass screening
  • patient acceptance of health care
  • patient satisfaction
  • quality assurance, health care
  • sensitivity and specificity

ASJC Scopus subject areas

  • Health Professions(all)

Cite this

Screening for major diseases in community pharmacies : a systematic review. / Ayorinde, Abimbola Adebukola; Porteous, Terry; Sharma, Pawana.

In: International Journal of Pharmacy Practice, Vol. 21, No. 6, 12.2013, p. 349-361.

Research output: Contribution to journalArticle

Ayorinde, Abimbola Adebukola ; Porteous, Terry ; Sharma, Pawana. / Screening for major diseases in community pharmacies : a systematic review. In: International Journal of Pharmacy Practice. 2013 ; Vol. 21, No. 6. pp. 349-361.
@article{a4263ce40049443292d8bb317170f973,
title = "Screening for major diseases in community pharmacies: a systematic review",
abstract = "OBJECTIVES: The aim of this systematic review was to assess the published evidence about the feasibility and acceptability of community pharmacy-based screening for major diseases.METHOD: Studies published between January 1990 and August 2012 involving community pharmacy-based screening interventions, published in the English language, were identified from electronic databases. Reference lists of included studies were also searched.KEY FINDINGS: Fifty studies (one randomised controlled trial, two cluster randomised studies, five non-randomised comparative studies and 42 uncontrolled studies) were included. The quality of most of these was assessed as poor. Screening was mostly opportunistic and screening tools included questionnaires or risk assessment forms, medical equipment to make physiological measurements, or a combination of both. Few studies assessed the accuracy of pharmacy-based screening tools. More than half of the screening interventions included an element of patient education. The proportion of screened individuals, identified with disease risk factors or the disease itself, ranged from 4{\%} to 89{\%}. Only 10 studies reported any economic information. Where assessed, patient satisfaction with pharmacy-based screening was high, but individuals who screened positive often did not follow pharmacist advice to seek further medical help.CONCLUSION: Available evidence suggests that screening for some diseases in community pharmacies is feasible. More studies are needed to compare effectiveness and cost-effectiveness of pharmacy-based screening with screening by other providers. Strategies to improve screening participants' adherence to pharmacist advice also need to be explored. This systematic review will help to inform future studies wishing to develop community pharmacy-based screening interventions.",
keywords = "community pharmacy services, humans, mass screening, patient acceptance of health care, patient satisfaction, quality assurance, health care, sensitivity and specificity",
author = "Ayorinde, {Abimbola Adebukola} and Terry Porteous and Pawana Sharma",
note = "{\circledC} 2013 Royal Pharmaceutical Society.",
year = "2013",
month = "12",
doi = "10.1111/ijpp.12041",
language = "English",
volume = "21",
pages = "349--361",
journal = "International Journal of Pharmacy Practice",
issn = "0961-7671",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "6",

}

TY - JOUR

T1 - Screening for major diseases in community pharmacies

T2 - a systematic review

AU - Ayorinde, Abimbola Adebukola

AU - Porteous, Terry

AU - Sharma, Pawana

N1 - © 2013 Royal Pharmaceutical Society.

PY - 2013/12

Y1 - 2013/12

N2 - OBJECTIVES: The aim of this systematic review was to assess the published evidence about the feasibility and acceptability of community pharmacy-based screening for major diseases.METHOD: Studies published between January 1990 and August 2012 involving community pharmacy-based screening interventions, published in the English language, were identified from electronic databases. Reference lists of included studies were also searched.KEY FINDINGS: Fifty studies (one randomised controlled trial, two cluster randomised studies, five non-randomised comparative studies and 42 uncontrolled studies) were included. The quality of most of these was assessed as poor. Screening was mostly opportunistic and screening tools included questionnaires or risk assessment forms, medical equipment to make physiological measurements, or a combination of both. Few studies assessed the accuracy of pharmacy-based screening tools. More than half of the screening interventions included an element of patient education. The proportion of screened individuals, identified with disease risk factors or the disease itself, ranged from 4% to 89%. Only 10 studies reported any economic information. Where assessed, patient satisfaction with pharmacy-based screening was high, but individuals who screened positive often did not follow pharmacist advice to seek further medical help.CONCLUSION: Available evidence suggests that screening for some diseases in community pharmacies is feasible. More studies are needed to compare effectiveness and cost-effectiveness of pharmacy-based screening with screening by other providers. Strategies to improve screening participants' adherence to pharmacist advice also need to be explored. This systematic review will help to inform future studies wishing to develop community pharmacy-based screening interventions.

AB - OBJECTIVES: The aim of this systematic review was to assess the published evidence about the feasibility and acceptability of community pharmacy-based screening for major diseases.METHOD: Studies published between January 1990 and August 2012 involving community pharmacy-based screening interventions, published in the English language, were identified from electronic databases. Reference lists of included studies were also searched.KEY FINDINGS: Fifty studies (one randomised controlled trial, two cluster randomised studies, five non-randomised comparative studies and 42 uncontrolled studies) were included. The quality of most of these was assessed as poor. Screening was mostly opportunistic and screening tools included questionnaires or risk assessment forms, medical equipment to make physiological measurements, or a combination of both. Few studies assessed the accuracy of pharmacy-based screening tools. More than half of the screening interventions included an element of patient education. The proportion of screened individuals, identified with disease risk factors or the disease itself, ranged from 4% to 89%. Only 10 studies reported any economic information. Where assessed, patient satisfaction with pharmacy-based screening was high, but individuals who screened positive often did not follow pharmacist advice to seek further medical help.CONCLUSION: Available evidence suggests that screening for some diseases in community pharmacies is feasible. More studies are needed to compare effectiveness and cost-effectiveness of pharmacy-based screening with screening by other providers. Strategies to improve screening participants' adherence to pharmacist advice also need to be explored. This systematic review will help to inform future studies wishing to develop community pharmacy-based screening interventions.

KW - community pharmacy services

KW - humans

KW - mass screening

KW - patient acceptance of health care

KW - patient satisfaction

KW - quality assurance, health care

KW - sensitivity and specificity

U2 - 10.1111/ijpp.12041

DO - 10.1111/ijpp.12041

M3 - Article

VL - 21

SP - 349

EP - 361

JO - International Journal of Pharmacy Practice

JF - International Journal of Pharmacy Practice

SN - 0961-7671

IS - 6

ER -